AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 292: E373-E393, 2007. First published July 18, 2006; doi:10.1152/ajpendo.00589.2005
0193-1849/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/E373    most recent
00589.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westermark, P. O.
Right arrow Articles by Lansner, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westermark, P. O.
Right arrow Articles by Lansner, A.

A mathematical model of the mitochondrial NADH shuttles and anaplerosis in the pancreatic beta-cell

Pål O. Westermark,1,2 Jeanette Hellgren Kotaleski,1 Anneli Björklund,3 Valdemar Grill,3,4 and Anders Lansner1

1Parallel Scientific Computing Institute/Computational Biology and Neurocomputing, Computer Science and Communication, Royal Institute of Technology, Stockholm, Sweden; 2Institute for Theoretical Biology, Humboldt University Berlin, Berlin, Germany; 3Department of Molecular Medicine, Endocrine and Diabetes Unit, Karolinska Institute and Hospital, Stockholm, Sweden; and 4Institute of Cancer Research and Molecular Medicine, Medical Faculty, Norwegian University of Science and Technology, Trondheim, Norway

Submitted 28 November 2005 ; accepted in final form 13 July 2006


    ABSTRACT
 TOP
 ABSTRACT
 Glossary
 METHODS AND MODEL
 RESULTS
 DISCUSSION
 APPENDIX: ORDINARY DIFFERENTIAL...
 GRANTS
 REFERENCES
 
The pancreatic beta-cells respond to an increased glycolytic flux by secreting insulin. The signal propagation goes via mitochondrial metabolism, which relays the signal to different routes. One route is an increased ATP production that, via ATP-sensitive K+ (KATP) channels, modulates the cell membrane potential to allow calcium influx, which triggers insulin secretion. There is also at least one other "amplifying" route whose nature is debated; possible candidates are cytosolic NADPH production or malonyl-CoA production. We have used mathematical modeling to analyze this relay system. The model comprises the mitochondrial NADH shuttles and the mitochondrial metabolism. We found robust signaling toward ATP, malonyl-CoA, and NADPH production. The signal toward NADPH production was particularly strong. Furthermore, the model reproduced the experimental findings that blocking the NADH shuttles attenuates the signaling to ATP production while retaining the rate of glucose oxidation (Eto K, Tsubamoto Y, Terauchi Y, Sugiyama T, Kishimoto T, Takahashi N, Yamauchi N, Kubota N, Murayama S, Aizawa T, Akanuma Y, Aizawa S, Kasai H, Yazaki Y, Kadowaki T. Science 283: 981–985, 1999) and provides an explanation for this apparent paradox. The model also predicts that the mitochondrial malate dehydrogenase reaction may proceed backward, toward malate production, if the activity of malic enzyme is sufficiently high. An increased fatty acid oxidation rate was found to attenuate the signaling strengths. This theoretical study has implications for our understanding of both the healthy and the diabetic beta-cell.

systems biology; potassium-dependent adenosine triphosphate channel-independent pathway of insulin secretion; reduced nicotinamide adenine dinucleotide; diabetes; fatty acid oxidation


THE PHYSIOLOGICAL TASK of the pancreatic beta-cell is to secrete insulin into the blood in response to a raised blood glucose level. The beta-cell is thus crucial for maintaining blood glucose homeostasis. This is underscored by the fact that beta-cell disorders are an important factor behind non-insulin-dependent diabetes mellitus (type 2 diabetes). The signal transduction in the pancreatic beta-cell that mediates glucose-stimulated insulin secretion (GSIS) involves the relay of an increased glycolytic flux to a raised ATP-to-ADP ratio (ATP/ADP) and to at least one other yet-undetermined factor (23, 100). In this study, we have used mathematical modeling to explore this relay system theoretically and to evaluate the signal propagation from glucose to different putative candidates for the undetermined factor as well as to ATP production.

A raised ATP/ADP ratio triggers insulin secretion via an increased intracellular calcium concentration. This is mediated by the closure of ATP/ADP-sensitive potassium channels, which results in the depolarization of the cell membrane and the opening of voltage-sensitive calcium channels (67). This mechanism is essentially necessary for insulin secretion and is referred to as the KATP-dependent pathway, or triggering pathway (40). The identity of the undetermined factor has been proposed to be either long-chain acyl-CoA (LC-CoA), NADPH, glutamate, or nucleotides (GTP, ATP, ADP) acting in some way to promote insulin secretion (100). Whatever the identity of this factor is, it is not alone sufficient for insulin secretion, but acts synergistically with the KATP-dependent pathway. This has been termed the KATP-independent pathway, or amplifying pathway (40).

Relaying involves the transfer of glycolytically produced carbon (pyruvate) and charge (NADH) to the mitochondria. NADH is transported to the mitochondrial matrix via the malate-aspartate (MA) shuttle (57) or directly to the respiratory chain via the glycerol-3-phosphate dehydrogenase (G3PDH) shuttle (56). An increased glycolytic flux is thus translated to a raised ATP/ADP ratio via an increased respiratory activity resulting from increased mitochondrial metabolism and shuttle activity. The relaying of the signal to the putative candidates for the KATP-independent pathway takes place via the mitochondrial metabolism (113). Cytosolic LC-CoA is proposed to increase via an increased citrate production. Citrate is cleaved by ATP-citrate synthase (ACS) to oxaloacetate and acetyl-CoA (ac-CoA), the latter of which is transformed to malonyl-CoA, which inhibits the mitochondrial carnitine palmitoyltransferase I transporter, causing LC-CoA to accumulate in the cytosol (23). NADPH is formed in the reactions catalyzed by cytosolic isocitrate dehydrogenase (IDHPc) and malic enzyme (ME) (59, 60). Glutamate has been proposed to be produced in the mitochondrial matrix by glutamate dehydrogenase (GDH) (64). Interestingly, ME and GDH catalyze, if operating in the directions suggested, cataplerotic reactions; i.e., they drain the tricarboxylic acid (TCA) cycle of carbons. Cataplerotic reactions have to be counterbalanced by anaplerotic reactions, and indeed the beta-cell has been shown to host a large quantity of the mitochondrial anaplerotic enzyme pyruvate carboxylase (PC) (59, 90).

One result from our modeling studies is that the glucose signal propagates strongly to ME and NADPH production, even at moderate ME activities. By doing so, the signal propagation to the respiratory chain weakens proportionally. The signal to ACS is more moderate but robust. Furthermore, there was a small net glutamate production in most scenarios evaluated here.

Another result concerns the findings of Eto et al. (26). Those investigators found that blocking of the NADH shuttles drastically impaired GSIS, whereas the glycolytic flux remained unchanged. Since the glycolysis demands continuous NADH reoxidation, this was taken as an indication of an unknown cytosolic factor reoxidizing the cytosolic NADH when the shuttles are blocked. We have simulated the experiments of Eto et al., and we show that it is not necessary to assume an unknown factor in order to explain their results.


    Glossary
 TOP
 ABSTRACT
 Glossary
 METHODS AND MODEL
 RESULTS
 DISCUSSION
 APPENDIX: ORDINARY DIFFERENTIAL...
 GRANTS
 REFERENCES
 

GSIS
Glucose-stimulated insulin secretion

LC-CoA
Long-chain acyl-CoA

MA shuttle
Malate-aspartate shuttle

PM shuttle
Pyruvate-malate shuttle

PMA shuttle
Pyruvate-malate-aspartate shuttle

GPDH
Glyceraldehyde-3-phosphate dehydrogenase

G3PDH
Glycerol-3-phosphate dehydrogenase

PDH
Pyruvate dehydrogenase

PC
Pyruvate carboxylase

CS
Citrate synthase

IDHm
Isocitrate dehydrogenase (mitochondrial, NAD-reducing)

IDHPm
Isocitrate dehydrogenase (mitochondrial, NADP-reducing)

IDHPc
Isocitrate dehydrogenase (cytosolic, NADP-reducing)

OGDH
2-oxoglutarate dehydrogenase

MDHm
Malate dehydrogenase (mitochondrial)

AATm
Amino aspartate transaminase (mitochondrial)

AATc
Amino aspartate transaminase (cytosolic)

MDHc
Malate dehydrogenase (cytosolic)

ACS
ATP citrate synthase

ME
Malic enzyme

Resp
Respiratory NADH consumption

FO
Fatty acid oxidation

LDH
Lactate dehydrogenase

GDH
Glutamate dehydrogenase

PFK
Phosphofructokinase

{gamma}
Gain (see Eq. 1)

C
Control coefficient (see Eq. 2)

{Psi}
Mitochondrial membrane potential (see Eq. 3)

v
Mass flux

j
Steady-state mass flux

q
Coupling strength (see Eqs. 8 and 9)


    METHODS AND MODEL
 TOP
 ABSTRACT
 Glossary
 METHODS AND MODEL
 RESULTS
 DISCUSSION
 APPENDIX: ORDINARY DIFFERENTIAL...
 GRANTS
 REFERENCES
 
The main subject of this study was to model the relaying of the glycolytic flux to respiration and to the production of cytosolic NADPH, ac-CoA, and mitochondrial glutamate. This is a highly nontrivial problem, since this relaying takes place via several interlocked metabolic cycles. Furthermore, we seek to reproduce and explain the findings of Eto et al. (26). In this section, we first describe the model and then turn to the measures used to assess the coupling between glycolytic flux and the four fluxes mentioned above.

Model Description

The present model considers glycolysis as the influx and describes the NADH shuttles, TCA cycle, and outfluxes via respiratory NADH consumption, and NADPH, ac-CoA, and glutamate production. An earlier study (65) incorporated a rudimentary model for the energy coupling between the cytosolic and mitochondrial metabolism in the beta-cell; however, it is far too simplified to be used to address the questions posed in the present study. Other previous models concerning the mitochondrial shuttles and the TCA cycle (21, 44, 71) were for other cell types and do not include all enzymatic reactions relevant to beta-cell biochemistry.

Our model comprises the biochemical reactions drawn in Fig. 1. This system consists of 19 enzyme-catalyzed reactions and 10 metabolites represented by the numbers listed in Table 1. Glycolytic flux is controlled by the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which produces pyruvate and NADH. Pyruvate may be consumed by lactate dehydrogenase (LDH), reoxidizing NADH, or it is transported into the mitochondria and is either decarboxylated by pyruvate dehydrogenase (PDH), producing ac-CoA and NADH, or carboxylated by PC, producing oxaloacetate. Fatty acid oxidation (FO) also produces ac-CoA and NADH. The TCA cycle is represented by the reactions catalyzed by citrate synthase (CS; citrate is considered to be in quasi-equilibrium with isocitrate via the aconitase reaction), the isocitrate dehydrogenases (IDHs; NADPH-producing IDHs in the cytosol and mitochondria, IDHPc and IDHPm; and NADH-producing IDH in the mitochondria, IDHm), 2-oxoglutarate dehydrogenase or {alpha}-ketoglutarate (OGDH; here we have for simplicity lumped the four reactions catalyzed by OGDH, succinate-CoA ligase, succinate dehydrogenase, and fumarate hydratase into a reaction block with a rate controlled by the physiologically irreversible enzyme OGDH), and mitochondrial malate dehydrogenase (MDHm). The NADH produced in the TCA cycle is reoxidized by respiration (Resp). Also, the reaction catalyzed by GDH is included in the model. We have assumed that the transports of pyruvate, citrate, isocitrate, 2-oxoglutarate, and malate across the mitochondrial inner membrane are fast compared with the enzymatic reactions (61) and thus are at quasi-equilibrium. Furthermore, alanine transaminase was not included in the model because it seems to have a low activity in beta-cells (97).


Figure 1
View larger version (14K):
[in this window]
[in a new window]

 
Fig. 1. Diagram of our model. Nos. refer to different metabolites as follows (see also Table 1): 1, citrate/isocitrate; 2, 2-oxoglutarate; 3, malate; 4, oxaloacetate (mit.); 5, oxaloacetate (cyt.); 6, pyruvate; 7, CoA; 1–7, ac-CoA; 8, NAD (mit.); 9, NAD (cyt.); 10, NADP (mit.). Directions of arrows define the stoichiometry of the model, mirrored in the rate equations and the differential equations A1. Solid arrows represent reversible reactions, dashed arrows represent irreversible reactions. Thicker arrows comprise the TCA cycle. The reactions consuming cytosolic or mitochondrial NAD(P) have the corresponding number in brackets after the enzyme abbreviation; reactions producing NAD(P) have the bracketed number written before the abbreviation.

 

View this table:
[in this window]
[in a new window]

 
Table 1. Definition of the shorthand number notation for chemical species included in the model as dynamic variables

 
The NADH produced in the cytosol by GAPDH is shuttled to the respiratory chain by the enzyme G3PDH or to the mitochondrial matrix by the MA shuttle. The MA shuttle consists of the reactions catalyzed by mitochondrial and cytosolic amino aspartate transaminase (AATm and AATc, respectively) and cytosolic and mitochondrial MDH (MDHc andMDHm). A PM shuttle is formed by the cycle consisting of the enzymes PC, MDHm, and ME if the MDHm-catalyzed reaction proceeds backward. This cycle has been proposed to be crucial for NADPH production (carried out by ME) in the beta-cell (59). Another cycle that has been suggested to be important in the beta-cell is the pyruvate-citrate shuttle, which involves the reactions catalyzed by ACS, MDHc, ME, PC, PDH, and CS (30). In this cycle, both the putative second messengers ac-CoA and NADPH are produced. However, in our analysis, we found the reaction cycle comprising PC, AATm, AATc, MDHc, and ME a cycle, which we denote the pyruvate-malate-aspartate (PMA) shuttle, to be the most prominent, as reported below.

Our model represents a module of the beta-cell biochemistry. By necessity, certain simplifications have to be made regarding the reactions on the boundary of the module. Strictly, the results will only hold for the module in isolation (i.e., in a constant surrounding). However, it is reasonable to believe that the behavior of the module is robust enough for an analysis of it to yield experimentally testable and meaningful predictions and insights. Important boundary parameters for the model assumed to be constant are glutamate and aspartate concentrations (affecting the AATs and GDH), ammonia concentration (affecting GDH), cytosolic ac-CoA/CoA ratio (affecting ACS), and factors affecting the respiratory rate. Also, we neglect the modulatory influence of adenine nucleotides on some enzymes (CS, IDH, GDH).

The dynamics of the model described graphically in Fig. 1 may be represented mathematically by a system of ordinary differential equations (ODEs), which is given in the APPENDIX. The different fluxes are described mathematically with rate equations, also given in the APPENDIX. Throughout this study, we use millimoles as the concentration unit, and millimoles per second as the unit for the rates of biochemical reactions, if nothing else is explicitly stated.

All rates are linearly dependent on the activities of the catalyzing enzymes, represented by the limiting rate V (often in the literature denoted Vmax). The limiting rates in our model were estimated from an extensive literature survey. The estimations are listed in Table 2, along with references to the literature. To transform the units given in the literature sources to our standard unit millimoles per second, either data directly from the same sources were used, or, if not given there, data from the review by Erecinska et al. (25) were used. Our approach was to examine different scenarios rather than a fixed parameter set, since living cells are variable chemical environments, enzyme concentrations are variable, and the experimental measurements are afflicted with significant measurement errors (1).


View this table:
[in this window]
[in a new window]

 
Table 2. Estimation of physiological ranges of the limiting rates of different enzymes in beta-cells from mouse, rat, and cell lines, given in mM/s

 
Study Outline and Measurements

We will begin our analysis of the model we have built up with an attempt to reproduce the results of Eto et al. (26). We will then proceed with a more general analysis of the signal propagation from the glycolytic flux to 1) the respiratory chain, 2) the cytosolic ac-CoA production by ACS, and 3) cytosolic NADPH production by ME and IDHPc. Glutamate production will also be discussed. To measure the coupling between the glycolytic signal and the four fluxes mentioned above, we introduce the gain, denoted {gamma}, defined

Formula 1(1)
representing the relative change in the steady-state level of the output signal x in response to a raised VGPDH, usually from 0.005 to 0.015 mM/s, which represents an increased glycolytic flux resulting from an increased glucose concentration. The gain should not be confused with flux control coefficients (31), denoted C, defined

Formula 2(2)
which only reflect the relative response of the response variable r to very small changes in enzyme activities. Here, however, we mostly take interest in the system response to larger changes, reflecting the physiological task of the beta-cell. In this context, we used the gain as a measure of system response to a glucose stimulus. ATP production is measured as being proportional to the mitochondrial membrane potential {Psi}. This is not a dynamic variable in our model, but we make a crude estimate and consider it to be proportional to jG3PDH and jResp, i.e.,

Formula 3(3)
This reflects the ratio between ATP production from mitochondrial NADH and cytosolic NADH entering the respiratory chain via the G3PDH shuttle, which is roughly 3:2. Here we have neglected the marginal contribution to {Psi} from mitochondrial FADH2 production.

Cytosolic LC-CoA production is measured as the flux via ACS (jACS). Cytosolic NADPH is produced by ME and IDHPc; hence,

Formula 4(4)

Net mitochondrial glutamate production was measured as

Formula 5(5)
where c is the ratio between the volumes of the cytosolic and mitochondrial compartments, here assumed to amount to 20 (30, 39).

Finally, for the reproduction of the results of Eto et al. (26), we need the glucose oxidation rate jGO, which we measure as

Formula 6(6)
and the flux via the dehydrogenases IDH (3 isoforms) and OGDH, jDH, which we measure as

Formula 7(7)


    RESULTS
 TOP
 ABSTRACT
 Glossary
 METHODS AND MODEL
 RESULTS
 DISCUSSION
 APPENDIX: ORDINARY DIFFERENTIAL...
 GRANTS
 REFERENCES
 
Reproduction of the Study of Eto et al. (26)

As an integral part of the model-building process, we investigated the ability of our model to reproduce the findings of the important study by Eto et al. These authors investigated different aspects of mouse beta-cell metabolism in four genotypes. These were the four combinations that arise from the ability to treat wild-type (wt) and G3PDH knockout (mut) mice with AOA (aoa– or aoa+), which inhibits AATc and AATm.1 The main aspects of these experimental findings that we consider in the context of the present model are:

  1. ) The four genotypes do not differ markedly in glucose consumption and oxidation.
  2. ) The mut/aoa+ genotype exhibits a reduced production of 14CO2 resulting from the oxidation of [6-14C]glucose compared with the other three genotypes. This corresponds to reduced flux via the IDHs and OGDH (90).
  3. ) Insulin secretion in response to a raised glucose concentration is impaired in the mut/aoa+ genotype compared with the other three genotypes.
  4. ) The change of the mitochondrial NAD(P)H autofluorescence in response to a raised glucose concentration is attenuated in the mut/aoa+ genotype compared with the other three genotypes.

Mice exhibit the special trait of having no beta-cell ME activity (60); hence, we here set VME = 0. We defined the G3PDH mutant by letting VG3PDH = 0. We modeled the degree of AOA inhibition by reducing VAATc and VAATm by different percentages; in particular, the aoa+ genotype was defined by a 96% reduction of the limiting rates, as achieved in the experimental study of Eto et al. We then calculated corresponding steady-state solutions, i.e., the solutions to Eq. system A2.

Our starting point was to explore whether conditions 1 and 2 above may be fulfilled simultaneously in our model. Intuitively, it may seem contradictory that glucose oxidation is decoupled from 14CO2 production from [6-14C]glucose. This has even been considered to be "biochemically impossible" (91). Furthermore, we asked what keeps the cytosolic reoxidation of NADH going if the shuttles are blocked. LDH has been suggested (91), although it is uncertain whether the low activity of LDH in the beta-cell seen experimentally (7, 90, 93, 97) would suffice to handle the load normally taken care of by the two shuttles. This was also investigated theoretically here.

When checking for compliance with condition 1, we demanded that, for the mut and/or aoa+ genotypes, jGO be >90% of jGO for the wt/aoa– genotype. When checking for compliance to condition 2, we considered the 14CO2 production from the flux via the IDHs and OGDH, jDH, and demanded that jDH for the mut/aoa+ be <75% of jDH for the wt/aoa– genotype, while at the same time, jDH for the mut/aoa– and wt/aoa+ genotypes be >90% of jDH for the wt/aoa– genotype. We explored different scenarios characterized by different enzyme activities. Given a scenario where conditions 1 and 2 were fulfilled, we validated the model by checking whether conditions 3 and 4 also were fulfilled.

An exploration of the parameter space is, due to its dimensionality, by necessity not exhaustive. Our strategy here was first to restrict the investigation to a selected set of parameters. We chose to restrict it to a few thousand combinations of the limiting rates V of some of the enzymes. Either the enzymes chosen have an experimentally more poorly characterized V, or the system is sensitive to it in the sense that the enzymes have high flux control coefficients over jDH. We selected the parameters VFO and VACS because we were unable to find good recent measurements of these limiting rates [although FO may be estimated to exhibit a rate in the same order of magnitude as GO (14)]. VIDHPc was selected because of highly conflicting experimental results concerning the presence and activity of this enzyme in the beta-cell (60, 95). We further introduced another degree of freedom for the IDHs with the factor idhinh, which modulates all three IDH limiting rates, since the activity of IDHm is modulated by Ca2+ and since IDHPm exhibits a high flux control coefficient over jDH (cf. Table 3). VLDH was selected since available data on the limiting rate of this enzyme are of low resolution, pointing only to a generally low rate, and since one of the objectives of the study was to test whether LDH is needed to compensate for lost shuttle activity. Finally, we selected the parameter VOGDH due to a high flux control coefficient over jDH (see below and Table 3). We let each limiting rate take three to five values spanning many orders of magnitude, e.g., take the values 0, 0.001, and 0.01. For each enzyme, each value was assigned a category, used later in the statistical analysis of the results. Table 4 lists the values that we let the different limiting rates take, along with the categories.


View this table:
[in this window]
[in a new window]

 
Table 3. Control coefficients CiDH of enzyme i over jDH at the parameter set satisfying conditions 1 and 2 (* in Table 4)

 

View this table:
[in this window]
[in a new window]

 
Table 4. Parameter values examined, with limiting rates given in mM/s

 
Three combinations of these limiting rates that cause the system to fulfill conditions 1 and 2 at VGPDH = 0.015 were found of the the 2,880 steady-state solutions representing all combinations of the six limiting rates. Results from other groups suggests that AOA actually may inhibit GSIS in wt islets (91), which suggests that conditions 1 and 2 could be very strict and not that general. Another possibility is that the activities of the enzymes are relatively fine-tuned.

One of the combinations is marked in Table 4 with one asterisk (*). The other two combinations differed only in the value for VFO, which was 0 and 0.001 mM/s, respectively. The flux control coefficients over jDH at this parameter set are given in Table 3. With this parameter set, we took a bird's eye view of the successive inhibition of the AATs and calculated steady-state solutions, i.e., solutions to equation system A2, letting the inhibition of AATc and AATm rise from 0 to 100%. Figure 2 shows the results of these calculations. Figure 2A shows the steady-state glucose oxidation as a function of AOA inhibition. The dots represent a 96% inhibition of the AATs as achieved experimentally by Eto et al. To directly compare our results with that of the experimental study of Eto et al., the corresponding histogram, Fig. 2C, is presented. Figure 2, B and D, show the corresponding steady-state flux jDH as a function of AOA inhibition. The mut/aoa+ genotype exhibits a marked deviation in the steady-state jDH, which is the most significant deviation evident from the histograms in Fig. 2, C and D. The bird's eye view presented in Fig. 2B reveals that AOA affects jDH also in the wt genotype, although more moderately. It should be noted that, although our results are in excellent agreement with the experimental data considered (compare Fig. 2, B and D, in the study of Eto et al.), the parameter combination used to simulate the experiments should, due to the course-grained distribution of the varied parameters, be regarded only as an approximate pointer to a region in parameter space representing a scenario that agrees with experimental observations.


Figure 2
View larger version (19K):
[in this window]
[in a new window]

 
Fig. 2. Reproduction of results of Eto et al. (26). A: steady-state value of jGO at different percentages of reduction of VAATm and VAATc. Solid line, wild type (wt); dashed line, mutant (mut); i.e., VG3PDH = 0. Dotted vertical line marks a 96% reduction of VAATm and VAATc. B: steady-state value of jDH for the same conditions as in A. C and D: histograms from data in A and B, sampled at 0 and 96% reduction of VAATm and VAATc, respectively.

 
Having concluded that our model accounts for the observations made by Eto et al., we asked which mechanism may be responsible for the maintenance of NADH reoxidation in the cytosol in the mut/aoa+ genotype. One may immediately note that it cannot be LDH, since VLDH = 0 in the selected parameter set! To answer this question, we first present a graphic overview of the distribution of the fluxes in the wt/aoa– and mut/aoa+ (at 96% inhibition of the AATs) genotypes, respectively, in Fig. 3. This overview shows a remarkable similarity between the genotypes; i.e., the system seems to be biochemically robust. In the overview, a "generalized TCA cycle" emerges, with one mitochondrial arm (IDHm, IDHPm, AATm, and OGDH) and one cytosolic arm (IDHPc, AATc, ACS, and MDHc). The arms converge to produce malate, and MDHm has to take care of the flux of both arms, a task that it handles gracefully despite the unfavorable equilibrium constant. The main difference between the genotypes is that the mut/aoa+ genotype directs a larger amount of flux via ACS at the expense of the flux via IDHPc and AATc. It appears that the mut/aoa+ genotype is able to compensate for lost AATc activity by increasing the flux via ACS.


Figure 3
View larger version (17K):
[in this window]
[in a new window]

 
Fig. 3. Overview of distribution of fluxes in the wt/aoa– genotype (A) and in the mut/aoa+ genotype (B). Thickness of arrows is directly proportional to magnitude of fluxes. All mitochondrial fluxes were transformed to cytosolic units (i.e., divided by c). As a reference, jGPDH = 3 µM/s in the diagrams.

 
Figure 4, A and B, is a magnification of Fig. 2, A and B, but with the solid curves representing the mut/aoa+ genotype. The dashed lines represent the same genotype but without ACS activity (i.e., VACS = 0). It is evident in the graph in Fig. 4A that the lack of ACS activity causes the glucose oxidation to stall when the inhibition of the AATs approaches 100%. Moreover, Fig. 2D shows a steady increase in the steady-state flux jACS when the AAT inhibition increases in the mut/aoa+ genotype with normal ACS activity. The straightforward interpretation is that the ACS route compensates for lost AAT activity, empowering MDHc to match the glucose oxidation rate (VLDH = 0 in the parameter set selected, which implies that, in the mut genotype, glucose oxidation matches jMDHc exactly at steady state). This is a possibility that, to our best knowledge, has not been pointed out before. Figure 4C shows that, in the absence of ACS activity, AATc keeps the flux going at much higher inhibition levels than when ACS is present. This also corresponds to a matching higher upkeep of the fluxes through the IDHs, and OGDH is the absence of ACS, as seen in Fig. 4B.


Figure 4
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 4. A–D: different fluxes as functions of magnitude of inhibition of AATm and AATc for the mut genotype (solid curves) and for the mut genotype with no ACS activity (dashed curves).

 
The parameter set used in the steady-state calculations so far was selected to fulfill conditions 1 and 2 above. We now proceed by investigating whether the model with the same parameters also may fulfill conditions 3 and 4. Figure 5A shows the gain in {Psi} for an increase of VGPDH from 0.005 to 0.025 mM/s. Again, the solid line represents the wt genotype, whereas the dashed line represents the mut genotype. We see that {gamma}{Psi} decreases in the mut genotype as the AAT inhibition approaches 100%. This may be considered as a validation of condition 3, although one has to keep in mind that the estimation of {Psi} is crude. Furthermore, Fig. 5B shows a more marked decrease in {gamma}[NAD(P)H]m at higher levels of AAT inhibition. This behavior is taken as a validation of condition 4.


Figure 5
View larger version (13K):
[in this window]
[in a new window]

 
Fig. 5. Gains in {Psi}, [NADPH]m, ACS, and IDHPc as functions of the grade of inhibition of AATm and AATc. Solid curves, the wt genotype; dashed curves, the mut genotype, with VG3PDH = 0.

 
Eto et al. furthermore registered a markedly reduced insulin secretion in response to a raised glucose level for the mut/aoa+ genotype. This is compatible with a loss of gain in {Psi}. We investigated the gains of two other output fluxes corresponding to signal candidates: jACS and jIDHPc. Figure 5C shows a consistently higher {gamma}ACS for the mut genotype, whereas the opposite is true for {gamma}IDHPc, as seen in Fig. 5D, especially at higher degrees of AAT inhibition. The prediction from this model is thus that abolished NADPH production via IDHPc may be involved in the impaired insulin response seen by Eto et al.

We stress that we can assert only that our model is in qualitative agreement with the results of Eto et al.; the experiments were made only either with no AOA or with AOA applied in excess.

In summary, we have shown that our minimal model is capable of reproducing the behavior described by conditions 1 and 2. The set of enzyme limiting rates that were selected to satisfy these two conditions were also found to satisfy conditions 3 and 4. This provides a validation of the model. So far, the model suggests that ACS and MDH, but not LDH, are responsible for the maintenance of cytosolic NADH reoxidation when the shuttles are inhibited. Furthermore, the impaired insulin response of the mut/aoa+ genotype may be due to impaired responses in {Psi} and in the NADPH-producing reaction catalyzed by IDHPc but not due to impaired citrate cleavage.

Investigations into Coupling Between Glycolytic Stimulus and Putative Response Fluxes and the Control Thereof

We here turn to the coupling between a glycolytic stimulus and the putative response fluxes. We investigated the more general case, applicable to, e.g., rat and human pancreatic beta-cells where ME is present, with the activity listed in Table 2 if nothing else is stated.

Parameter search and validation. We applied the same strategy as above and considered all possible combinations of the limiting rates listed in Table 4. Here, we applied broader goodness criteria, following several studies of mostly rat beta-cells from several laboratories (30, 52, 54, 61, 62). We addressed the steady-state concentrations of the metabolites and required the citrate concentration and the [citrate]/[malate] ratio to be in reasonable accord with recent experimental observations made in these studies. We required citrate to be present in more than 0.05 mM and the [citrate]/[malate] ratio to exceed 0.5, at a high glycolytic influx rate VGPDH = 0.025. Furthermore, {gamma}{Psi}, {gamma}ACS, and {gamma}NADPHc had to be positive. Of the 2,880 parameter combinations, 645, or 22%, satisfied these requirements.

Since there is no consensus regarding the question whether glutamate is a coupling factor (11, 17, 63, 64, 114), we did not constrain our model with respect to total glutamate production or consumption. However, we noted that, of the 645 accepted parameter combinations, 407 corresponded to a net glutamate production. The mean glutamate production rate in these 407 scenarios was ~2 µM/s. Furthermore, in all the 645 accepted parameter combinations, jGDH was positive with a low net flux with a mean of 0.6 µM/s.

Some statistics from this parameter inventory are given in Table 5. The distribution of the accepted parameter combinations is given under the heading "Counts". Each count for each enzyme falls under one of five categories, ordered according to increased parameter values (see Table 4). The lowest limiting rates of OGDH, FO, and ACS are distinctly absent from the group of accepted parameter combinations, and the limiting rate for IDHc seems to be either high or low, whereas the LDH limiting rate and idhinh seem to be evenly distributed. Further tendencies in the data are revealed by the correlation coefficients, also presented in Table 5. The correlation coefficients were taken between the numbers defining the categories, as given in Table 4. The strongest correlation by this measurement is that between the general inhibition of all the IDHs and IDHPc. There is also a negative correlation between OGDH and ACS, enzymes which are present in alternate pathways from citrate to malate. Furthermore, there is a positive correlation between FO and ACS. Correlation coefficients only measure the strength of a linear relationship between two variables and thus are blind to nonlinear tendencies. Therefore, we also list the correlation ratios between the categories in Table 5. The correlation ratio is equal to the absolute value of the correlation coefficient for a purely linear relationship, greater otherwise (47). In two cases, the correlation coefficients miss significant correlations. The first of these concerns the correlation between VIDHPc and idhinh. The counts of the categories for these parameters are therefore presented in Table 5. It is here revealed that idhinh more often attains a low value at either low or high values of VIDHPc, but more seldom at intermediate values of the latter. Thus a high value of VIDHPc is associated with high limiting rates for the two mitochondrial IDHs, and the same goes for low values of VIDHPc. The second markedly nonlinear correlation is the one between VIDHPc and VACS. The counts of the categories of these limiting rates are also presented in Table 5. Here, low and high values of VACS correspond to low values of VIDHPc, whereas intermediate values of VACS correspond to high values of VIDHPc.


View this table:
[in this window]
[in a new window]

 
Table 5. Statistical measures of the accepted parameter combinations for nonmouse beta-cell

 
We further chose a default "nonmouse" parameter set out of the 645 acceptable ones, which is marked with two asterisks (**) in Table 4. This parameter set was used for closer investigations of the relations between one parameter at a time and different model properties, as reported below. The parameter set was chosen so that VFO is in the same order of magnitude as VGPDH, which complies with recent observations (14), and so that the other limiting rates comply with the intervals in Table 4, with the exception that the idhinh value renders VIDHm and VIDHPm somewhat lower than the experimentally found values. To validate this parameter set, we then first examined the variation of the cytosolic citrate concentration and [citrate]/[malate] ratio at different degrees of glycolytic influx (Fig. 6). Citrate concentration rises with VGPDH, whereas the opposite is true for the [citrate]/[malate] ratio. This behavior has been observed in two different laboratories (30, 61). An important factor behind the larger increase in the malate concentration is that the equilibrium constant of MDHm is very low (see Table 7).


Figure 6
View larger version (7K):
[in this window]
[in a new window]

 
Fig. 6. Cytosolic citrate concentration rises (A), whereas cytosolic [citrate]/[malate] ratio falls (B), with increasing glycolytic flux (VGPDH).

 

View this table:
[in this window]
[in a new window]

 
Table 7. Equilibrium constants used in the model

 
Gains of the glycolytic signal toward {Psi}, ACS (LC-CoA production), and NADPHc. The mean values of the gains of {gamma}{Psi}, {gamma}ACS, and {gamma}NADPHc for the 645 accepted parameter combinations were 0.52, 1.3, and 3.7, respectively, with respective standard deviations 0.25, 0.94, and 1.6. Hence, NADPHc exhibits a particularly strong gain and is therefore a strong output signal.

We examined the correlation coefficients between the categories of the parameters and the gains, with results presented in Table 5. First, there is a positive correlation between idhinh and {gamma}ACS, meaning that a general inhibition of the IDHs correlates with a stronger output signal from ACS. Second, somewhat unexpectedly, there is a negative correlation between VIDHPc and {gamma}NADPHc, whereas the correlation between VIDHPc and {gamma}ACS is positive. Third, there are positive correlations between VOGDH and the gains of {Psi} and NADPHc. Fourth, again unexpectedly, the correlation between VACS and {gamma}ACS was negative. And finally, there are strong negative correlations between VFO and all gains. This was further investigated as reported below.

Distribution of fluxes. We now turn to the closer investigations of the model using the nonmouse parameter set, which will be used in all of the following, unless otherwise explicitly indicated. We again made a pair of snapshot surveys of the flux distribution in our model (Fig. 7). Two observations deserve mentioning. First, there is extensive cycling of carbons in the reaction cycle comprised by PC, AATm, AATc, MDHc, and ME, the PMA shuttle. Second, with a lower GDH activity (Fig. 7B), the MDHm reaction goes backward. This is investigated further below.


Figure 7
View larger version (18K):
[in this window]
[in a new window]

 
Fig. 7. Distribution of fluxes with the nonmouse parameter set at VGPDH = 0.015 and with VGDH = 0.5 (A) and VGDH = 0.1 (B). Thickness of arrows correspond to magnitude of fluxes; as a reference, jGPDH is ~0.3 µM/s in the diagrams.

 
Effect of fatty acid oxidation on the gains. We continued investigating the effect of fatty acid oxidation, i.e., of VFO, on the gains. The gains, which measure the relative change in {Psi}, ACS, and NADPHc in response to increased glycolytic flux, decrease with increased VFO (Fig. 8), whereas the absolute fluxes increase with increased VFO (Fig. 8, insets). These results are suggestive, as several studies (92, 101, 117) show the same behavior of insulin secretion with regard to glucose concentration and fatty acid supply: the basal secretion, present at low glucose levels, is stimulated by a high fatty acid supply, but the glucose response is weaker at this high fatty acid supply; i.e., the relative change in insulin secretion in response to an increased glucose oxidation is attenuated. Also (Fig. 8D), the cytosolic citrate concentration increases when VFO increases, whereas the rate of the PDH reaction decreases (Fig. 8E). These two effects are classic components of the Randle cycle (84), which defines different mechanisms of downregulation of glucose oxidation in response to an increased fat metabolism. Citrate here is thought to modulate the glycolytic flux via inhibition of phosphofructokinase (PFK). Moreover, an increase in VFO stimulates the rate of the PC reaction (Fig. 8E). This is not surprising, since ac-CoA, the product of fatty acid oxidation, is an allosteric activator of PC but an inhibitor of PDH. PC is activated more than PDH is inhibited, and in the steady state this has to be balanced by an increased flux via ME. This is an important factor of the rise of jNADPHc.


Figure 8
View larger version (17K):
[in this window]
[in a new window]

 
Fig. 8. Gains of {Psi} (A), ACS (B), and NADPHc (C) fall with increased VFO. Insets: absolute value of the fluxes for VGPDH = 0.005 (solid curve) and for VGPDH = 0.015 (dashed curve), which are all seen to increase as VFO increases. D: cytosolic citrate concentration rises with VFO. E: rate of the PDH reaction falls with VFO, whereas the flux via PC increases.

 
In summary, our results predict that an altered fatty acid oxidation rate directly affects the glucose signaling via metabolic pathways. This may constitute a component of lipotoxicity in addition to genetic regulation and ROS accumulation (19, 46). We also predict an increased flux via PC as the rate of fatty acid oxidation increases.

Effect of GDH on the gains. Leucine and its nonmetabolizable analog BCH have long been known to stimulate insulin secretion, presumably via the allosteric activation of GDH by these compounds (38, 94). Here, we investigated the influence of a modulated GDH activity both on the gains (i.e., on GSIS) and on the absolute fluxes (pertinent to leucine-stimulated insulin secretion). The fluxes and gains are calculated as functions of VGDH [the results are applicable to, e.g., leucine activation of GDH, since leucine increases the apparent limiting rate of GDH (29)], and the results are shown in Fig. 9, AC.


Figure 9
View larger version (18K):
[in this window]
[in a new window]

 
Fig. 9. Gains of {Psi} (A), ACS (B), and NADPHc (C) all rise with increased VGDH, whereas absolute flux j{Psi} is the only one to increase, as seen in insets. D: cytosolic citrate concentration falls when VGDH is increased. E: absolute flux via GDH is positive (toward glutamate formation) for the range of VGDH analyzed. F: in mitochondria, there is always net glutamate consumption (dashed curve), whereas at the whole cell level, glutamate is produced at a lower rate for VGPDH = 0.005 (dashed-dotted curve) than for VGDH = 0.015 (solid curve). G: flux via MDHm goes backward at lower GDH activities.

 
The gains of {Psi} and NADPHc both rise as GDH is activated, while the gain of ACS reaches a maximum and then decreases slightly. However, as seen in the insets, it is only the rise in the gain of {Psi} that is accompanied with a rise in the corresponding flux. Thus, when interpreting the present model, we may safely say only that leucine stimulation of GDH results in an augmentation of the KATP-dependent pathway; the effect on the NADPHc production is inconclusive (smaller fluxes but higher gain). Stimulation of GDH also decreases the citrate concentrations (Fig. 9D). This may be an important link to the glycolysis in the case that citrate modulation of PFK affects the glycolytic rate. Shown in Fig. 9E is the flux via GDH as a function of VGDH, and the flux is always toward glutamate production. In Fig. 9, the total mitochondrial and cellular glutamate production is shown. There is a net consumption of glutamate in the mitochondria, but when AATc is also taken into consideration, it is seen that there is a cellular net production, which is stimulated by an increased VGPDH. To get a summarizing picture of how increased GDH activity increases glutamate consumption and NADH production, we calculated some concentration and flux control coefficients, which are presented in Table 6. The increase in VGDH results in a reduced 2-oxoglutarate concentration and an increased backward flux in AATm, causing the mitochondrial glutamate consumption to rise. This is coupled to an increased flux via MDHm, which is the dominating factor behind the increased NADH production rate. The dependence of jMDHm on VGDH is shown in Fig. 9G, which interestingly predicts negative flux via MDHm at lower values of VGDH. We will investigate this further below.


View this table:
[in this window]
[in a new window]

 
Table 6. Control coefficients for VGDH over different response variables r at VGPDH = 0.015

 
In summary, or results show that an increased VGDH stimulates the substrate supply to respiration but attenuates jACS and jNADPHc, most markedly at lower activities of GDH. The flux via GDH is in the direction toward glutamate formation for all parameter combinations, including the VGDH we have examined. Also, with the transaminases taken into consideration, there is a net glutamate production by the metabolic module that we study here, albeit low compared with the total glutamate concentration.

Energy Coupling of the System and the Direction of the MDHm Reaction

We addressed the general question of the coupling of glycolytically produced carbon (i.e., pyruvate) and charge (i.e., NADH) to mitochondrial NADH production and to cytosolic ac-CoA and NADPH production. As a measure of the degree of coupling between glycolytic flux and i, where i may be mitochondrial NADH production, ACS flux, or cytosolic NADPH production, we define

Formula 8(8)
and

Formula 9(9)
as the forward (from glycolysis to i) and backward (from respiration to i) coupling strengths, respectively. The forward coupling strength measures how a small increase in glycolytic flux influences the respiratory rate, and vice versa for the backward coupling strength. Thus, theoretically, qFormula 9≤5, the maximal NADH yield of one triose molecule. Since we have observed that in our model the MDH reaction can be made to go backward when the ME catalyzed reaction is effective, we were motivated to study whether this may be correlated with a weaker coupling between the glycolysis and the respiratory chain and with a stronger coupling between the glycolysis and NADPH production. ME could then essentially be directing the electron flux from respiration to cytosolic NADPH production. In Fig. 10A, the forward coupling strengths have been plotted as functions of VME. These curves show a remarkable reciprocal relationship between qFormula 9 and qFormula 9. For low values of VME, qFormula 9 lies around 1.5, whereas qFormula 9 is very low, around 0.1. As the ME activity increases, a dramatic shift occurs, where the roles are switched and glycolytic flux becomes most tightly coupled to cytosolic NADPH production: ME "overtakes" the forward coupling from respiration. This sliding from coupling via respiration to coupling via NADPH represents an important difference between mouse on one hand, which according to our model couples the glycolytic flux mainly to respiration, and rat and human on the other hand, which couple glycolytic flux mainly to NADPH production, at least when VME is sufficiently high. The snapshot in Fig. 7B further shows what happens: a new cycle consisting of the reactions catalyzed by PC, MDHm, and ME emerges due to the ME activity.


Figure 10
View larger version (9K):
[in this window]
[in a new window]

 
Fig. 10. A: forward coupling strength qfw as defined in the text for 4 different fluxes. B: backward coupling strength qbw for 4 different fluxes.

 
On the other hand, as shown in Fig. 10B, the backward coupling strength is significant only for cytosolic NADPH production. This means that respiration is never significantly energetically coupled to glycolysis: an activation of the respiratory chain will not result in a corresponding increase in the glycolysis but rather in a reduced cytosolic NADPH production.

The tug-of-war between ME and respiration is illustrated from a different angle in Fig. 11. In Fig. 11A, we see how an increased VME "pulls" the MDHm flux below zero, which happens more easily if VGDH is low. On the other hand, an increase in VResp "pulls" jMDHm in the other direction, toward higher values, which is shown in Fig. 11B. Again, lower VGDH values are associated with more negative MDHm fluxes. The correlation between jME and jMDHm is remarkably linear, as seen in Fig. 11C. The curves were virtually independent of whether VME or VResp was varied in the continuation algorithm. For a given MDHm flux, higher ME flux correlates with a lower GDH activity, and vice versa. This can also be seen in the flux distribution snapshots of Fig. 7. Also, jME and jResp were linearly negatively correlated (Fig. 11D), again robustly in the sense that the curves were independent of whether VME or VResp was varied in the continuation algorithm. This correlation represents a tug-of-war between mitochondrial NADH production and cytosolic NADPH production.


Figure 11
View larger version (17K):
[in this window]
[in a new window]

 
Fig. 11. A: as VME increases, MDHm flux is pulled backward. GDH activities in all panels as indicated in the legend. B: increased respiratory NADH consumption pulls MDHm in the forward direction. C: for both examined GDH activities, the relation between jMDHm and jME is reciprocal and essentially linear. D: relations between jResp and jME are also reciprocal and essentially linear.

 

    DISCUSSION
 TOP
 ABSTRACT
 Glossary
 METHODS AND MODEL
 RESULTS
 DISCUSSION
 APPENDIX: ORDINARY DIFFERENTIAL...
 GRANTS
 REFERENCES
 
We have used mathematical modeling to investigate how the beta-cell TCA cycle and NADH shuttles operate as an isolated module. The model represents a fairly compact description of this module in the sense that it consists of only ten ODEs while still integrating much experimental data on the molecular level and having a behavior that agrees with many experimental observations on the systemic level. Furthermore, the model generated diverse experimentally testable predictions. It also fills a previously empty gap among the theoretical (biophysical) models of the beta-cell. We must emphasize that the parameters of the model in some cases are subject to considerable uncertainties. Hence, we evaluated a multitude of scenarios where some limiting rates were allowed to vary by several orders of magnitude.

It is our hope that the results of this parameter inventory are amenable for comparison to future experimental studies of the expression profile of the beta-cell. For instance, future experimental studies may compare expression profiles with the correlations between the ACS and IDH activities obtained in this study. Our parameter inventory was course-grained and should be regarded as a first step toward a more complete quantitative characterization of the beta-cell. In our opinion, the road toward this goal goes via successive steps of model refinements against experimental data.

The model successfully reproduced the results of Eto et al. (26) and suggested that the flux via ACS may compensate for lost AATm activity, allowing NADHc to be reoxidized by MDHc. An experimental test for this would be to inhibit ACS in addition to the AATs and G3PDH. If the glucose oxidation is then still not attenuated, our model would be falsified.

Our model predicts a particularly strong signal transmission from an increased glycolytic flux to NADPHc production. This is linked to the high flux through the PMA shuttle, the latter which in fact allows cytosolic NADH to be converted to NADPH via the reaction series catalyzed by MDHc and ME. On this basis, we conclude that investigations into possible effects of NADPH in the beta-cell should continue (50).

An increased fatty acid oxidation attenuated the gains of the output signals, and at the same time it increased the absolute value of the fluxes. This is a behavior that has experimental support (14, 53, 92, 117). Regarding the effects of an increased fatty acid oxidation in the beta-cell, one usually considers acute effects, occurring on a metabolic time scale, and of long-term effects, resulting, e.g., from altered gene expression (12). Our results support a view that acute effects play an important role. It is also relevant to mention here the Randle cycle (84), which is a general term for the feedback mechanisms originally thought to attenuate glucose oxidation in response to a raised fatty acid oxidation. Our results highlight the metabolic parts of the Randle cycle, i.e., the fatty acid oxidation-induced attenuation of jPDH and increased cytosolic citrate concentration. The latter effect may inhibit the catalytic rate of PFK and will be examined in the context of glycolytic oscillations elsewhere. Our model may also help in partially reinterpreting certain experimental results. For instance, Roduit et al. (88) found that lowering the malonyl-CoA concentration by overexpressing malonyl-CoA decarboxylase attenuated GSIS. They attributed this effect to the resultant lower LC-CoA concentration in the cytosol. Our results predict that the increased fatty acid oxidation caused by the lower malonyl-CoA levels may have contributed to the attenuated GSIS as well.

A controversial subject is the direction of the GDH flux in the beta-cell. This is related to the hypothesis that glutamate is a coupling factor in GSIS, where GDH has been proposed to mediate an increased glutamate concentration in response to a raised glucose consumption (64), a hypothesis later refuted (11, 63, 114). Our model predicts that the GDH flux is directed toward glutamate. However, the GDH flux is quite moderate, although the total glutamate production usually is larger due to cytosolic glutamate production via AATc (AATm is always in the direction of glutamate consumption due to the electrogenic aspartate transporter). A small increase in the net production of glutamate in response to a raised glycolytic flux is also predicted by our model, although probably not enough to change the glutamate pool significantly, in line with experimental observations (63). It is, however, possible that a more detailed analysis of glutamate metabolism may yield additional insights. We conclude that our results should be possible to reconcile with recent experimental data (16, 17, 51), which reveal a small increase in the glutamate pool and a small decrease in the aspartate pool when the glucose level is increased. One should note that Li et al. (51) attributed this to mitochondrial glutamate production via AATm, whereas our results point to AATc being the probable cause. Furthermore, that study proposed glutamine, which is produced from glutamate, ATP, and NH4+ by glutamine synthetase, as a putative coupling factor in insulin secretion. The present model could be extended in order to evaluate this hypothesis. A new result is that activation of GDH may result in a decreased cytosolic citrate concentration. Since citrate is an allosteric inhibitor of PFK, this has the potential of being a feedback loop of importance for leucine-stimulated insulin secretion. A fuller analysis of glutamate metabolism is a suitable subject for further modeling studies.

An interesting prediction from our model is that the presence of ME may pull the MDH reaction in the backward (NADH-consuming) direction. This would have the effect of creating a short PM cycle consisting of the reactions catalyzed by PC, MDHm, and ME, which would divert the mass flux from the classical TCA cycle. Lu et al. (55) found in a thorough study, where they used 13C isotopomer analysis to track carbon flow from pyruvate to the TCA cycle, that pyruvate to a large extent is involved in what they term "pyruvate cycling," essentially the same as the pyruvate-citrate cycle. Their data were found to fit only a model in which there exists two separate compartmentalized pyruvate pools. However, the mathematical model they used did not allow the possibility that the MDHm-catalyzed reaction might proceed backward. It is possible that the assumption of two separate pyruvate compartments is unnecessary if the short PM cycle and the PMA cycle are taken into consideration. The possibility that the MDH reaction may run backward in the presence of ME activity, implying that the TCA cycle is not operative in its classical sense, may be important for other cell types too. This relationship between MDH and ME has to our knowledge not been stated explicitly before.

The beta-cell has attracted much attention from theoretical investigators (110). The complex electrophysiology of the beta-cell has already been considerably elucidated by mathematical modeling efforts (10). The electrophysiology is coupled to the metabolism at least via the KATP channel. An interesting hypothesis with much experimental support is that oscillations in the glycolysis may modulate the electrophysiological behavior (111). A realistic model of the coupling between glycolysis and ATP production has, however, been lacking, and the present model should fill part of this gap. It should thus be suitable as a template that, maybe in a simplified form, could be integrated in an emerging full-scale model of GSIS, encompassing all steps from glucose to insulin secretion.


    APPENDIX: ORDINARY DIFFERENTIAL EQUATIONS, EQUILIBRIA, AND RATE EQUATIONS
 TOP
 ABSTRACT
 Glossary
 METHODS AND MODEL
 RESULTS
 DISCUSSION
 APPENDIX: ORDINARY DIFFERENTIAL...
 GRANTS
 REFERENCES
 
Ordinary Differential Equations

Each of the 10 metabolite concentrations modeled as dynamic variables is normalized according to Table 1, and we use the notation xi to designate the concentration of metabolite i divided by the corresponding normalization constant. The metabolites are produced and consumed by reactions with rates denoted vi, where i represents the catalyzing enzyme. The ODE system then becomes, with stoichiometry according to Fig. 1:

Formula A1(A1)

The different factors fi follow from the quasi-equilibria that are assumed in the model, which are described in detail in the next section along with the fi factors. All of the different rates are functions of metabolite concentrations, substrates, and products, as well as activators and inhibitors.

In the present work, we analyzed only the steady state, i.e., solutions to the equation system

Formula A2(A2)

This corresponds to most experimental settings, where measurements are made after incubation under different conditions. An analysis of the temporal aspects of the model has also been made and will be presented elsewhere. The solutions to equation system A2 were usually calculated as functions of some model parameters. For this we used a Moore-Penrose continuation algorithm implemented in the software package MATCONT (24).

Equilibria

To our best knowledge, the activities of the different mitochondrial carriers have not been determined quantitatively with high resolution but appear to be quite high (61). To keep our model minimal, we thus treat the transport reactions as being in quasi-equilibrium. This allows us to determine the partitioning between the cytosolic and mitochondrial compartments as discussed below. We have kept this analysis in line with the current knowledge of mitochondrial carriers, reviewed recently by Palmieri (75).

Pyruvate is a monovalent molecule and is transported across the mitochondrial inner membrane electroneutrally, in exchange with a hydroxide ion through an antiport. Equilibrium is thus displaced from unity only due to the pH difference of ~0.3–0.4 (more acidic in the cytosolic and intermembrane compartments) that is "felt" by the anions subject to transport (103). This is described by the equation

Formula A3(A3)

Malate, which is divalent, is exchanged electroneutrally with divalent phosphate by means of the dicarboxylate carrier. Monovalent phosphate, necessary for ATP synthesis, is electroneutrally transported with a proton or in exchange with a hydroxide ion, thus assumed to obey the equation

Formula A4(A4)

If we equate the equilibria between monovalent and divalent phosphate in both compartments, i.e.,

Formula A5(A5)
we may write

Formula A6(A6)

Furthermore, malate and 2-oxoglutarate are carried across the mitochondrial membrane by means of an electroneutral antiport. Assuming that malate attains equilibrium according to Eq. A6, we may write

Formula A7(A7)

Malate is also electroneutrally exchanged with a trivalent (iso)citrate molecule and a proton through the tricarboxylate carrier, which allows us to write

Formula A8(A8)

The equilibria so far calculated roughly agree with experimental observations (103). Glu